NIH PAR · NIDCR · UG3, UH3
PAR-25-057: NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
To support UG3/UH3 phased, cooperative agreement research applications to plan and implement clinical trials within the mission of the National Institute of Dental and Craniofacial Research (NIDCR)
- NOFO number
- PAR-25-057
- Type
- PAR
- Activity code
- UG3UH3
- Primary institute
- NIDCR · National Institute of Dental and Craniofacial Research
- Clinical trials
- Required
- Posted
- Oct 23, 2024
- Opens
- Jan 7, 2025
- Expires
- Jan 7, 2028
PAR-25-057 due dates
3 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 07, 2025 | March 07, 2025 | May 08, 2025 | July 2025 | October 2025 | December 2025 |
| June 06, 2025 | July 07, 2025 | September 04, 2025 | November 2025 | January 2026 | April 2026 |
| October 07, 2025 | November 06, 2025 | January 06, 2026 | March 2026 | May 2026 | July 2026 |
| February 09, 2026 | March 09, 2026 | May 8, 2026 | July 2026 | October 2026 | December 2026 |
| June 08, 2026 | July 08, 2026 | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 08, 2026 | November 09, 2026 | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 08, 2027 | March 08, 2027 | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 07, 2027 | July 07, 2027 | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 07, 2027 | November 08, 2027 | Not Applicable | March 2028 | May 2028 | July 2028 |
Projects funded under PAR-25-057
NIH RePORTER lists 3 projects funded under PAR-25-057 in FY2022–FY2026, with $1.7M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
3
Distinct projects, FY2022–FY2026
New awards
3
Type 1 (new project) award records
NIH funding
$1.7M
Award dollars under PAR-25-057, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 3 | 3 | $1.7M |
Institutions with the most funding
- University of California, San Francisco$1.1M · 2 projects
- Mayo Clinic Rochester$576K · 1 project
Funding institutes
- NIDCR$1.7M · 3
Activity codes funded
- UG33 records
Most recent new awards
- Comprehensive Periodontal Therapy to Improve Oral and Cardiometabolic Health in Prediabetes (opens NIH RePORTER)
Mayo Clinic Rochester · 1UG3DE035059-01A1 · NIDCR · Notice Aug 14, 2026
$576KUG3
- XERO study: A Phase I study of CVGN8 for the treatment of Radiation-Induced Xerostomia (opens NIH RePORTER)
University of California, San Francisco · 1UG3DE036295-01 · NIDCR · Notice Aug 11, 2026
$525KUG3
- A Pivotal Phase III Multi-Site Clinical Trial of High-Frequency Repetitive Transcranial Magnetic Stimulation at Primary Motor Cortex for Trigeminal Neuropathic Pain (opens NIH RePORTER)
University of California, San Francisco · 1UG3DE036325-01 · NIDCR · Notice Aug 11, 2026
$572KUG3
What its predecessor PAR-21-160 funded
PAR-25-057 reissues PAR-21-160. Its funding history is the best guide to who wins under this program: 10 projects and $9.1M in FY2022–FY2026.
Projects funded
10
Distinct projects, FY2022–FY2026
New awards
5
Type 1 (new project) award records
NIH funding
$9.1M
Award dollars under PAR-21-160, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 1 | 1 | $559K |
| FY2023 | 1 | 0 | $714K |
| FY2024 | 2 | 1 | $1.0M |
| FY2025 | 5 | 3 | $2.8M |
| FY2026 | 6 | 0 | $4.1M |
Institutions with the most funding
- University of Florida$3.4M · 2 projects
- Univ of North Carolina Chapel Hill$2.4M · 4 projects
- Wake Forest University Health Sciences$2.3M · 2 projects
- Rise Therapeutics, LLC$979K · 2 projects
Funding institutes
- NIDCR$9.1M · 15
Activity codes funded
- UH310 records
- UG35 records
Most recent new awards
- A Novel Immunological-Directed Probiotic for the Treatment of Sjögren’s Syndrome (opens NIH RePORTER)
Rise Therapeutics, LLC · 1UG3DE034134-01A1 · NIDCR · Notice Aug 14, 2025
$429KUG3
- Effectiveness of an Early Intensive Preventive Dental Program by Oncology Providers to Reduce Dental Disease and Improve Compliance in Head and Neck Cancer Patients: OraRad IPDP (opens NIH RePORTER)
Wake Forest University Health Sciences · 1UG3DE035104-01 · NIDCR · Notice Aug 14, 2025
$681KUG3
- Safety and analgesic efficacy of marine lipid precursors of specialized pro-resolving mediators in adults with chronic temporomandibular pain. (opens NIH RePORTER)
Univ of North Carolina Chapel Hill · 1UG3DE033354-01A1 · NIDCR · Notice May 30, 2025
$604KUG3
- A Phase II Randomized Assessment of Sparing Parotid Ducts via MRI Sialography for Reduced Patient Reported Xerostomia (opens NIH RePORTER)
Univ of North Carolina Chapel Hill · 1UG3DE033389-01 · NIDCR · Notice Apr 16, 2024
$357KUG3
- Photobiomodulation for the management of Temporomandibular disorder pain (opens NIH RePORTER)
University of Florida · 1UG3DE030433-01A1 · NIDCR · Notice Jul 1, 2022
$559KUG3
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-25-057. Contact the program officer at the institute that fits your research before applying.
- NIDCR · National Institute of Dental and Craniofacial Research
- none
Related notices
Jan 28, 2026 · NOT-OD-26-029
NIH Removing AIDS Application Due Dates from NOFOs.
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Notices of Special Interest (NOSIs)
NIH has attached 11 NOSIs to PAR-25-057; none are active now. A NOSI flags a topic an institute wants to fund through this NOFO.
Award terms
- Application types allowed
- NewResubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are limited to less than 400,000 in direct costs for the UG3 phase; Application budgets for the UH3 phase are not limited but need to reflect the actual needs of the proposed project.If the budget exceeds direct costs of 500,000 or more in any year, applicants must follow the NIDCR policy for Grant Applications Requesting 500,000 or More in Direct Costs for Any Project Year.
- Project period
- The total project period may not exceed one year for the UG3 phase and five years for the UH3 phase. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-21-160.
Other open NOFOs for UG3, UH3
- PAR-27-015Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)NIDCR · next due Oct 16, 2026
- PAR-25-062Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)NIDCR · next due Nov 9, 2026
- PAR-25-188NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)NIDCR · next due Feb 8, 2027
- PAR-25-296Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)NCATS · next due Oct 19, 2026
- PAR-24-293Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)NINDS · next due Jan 15, 2027
- PAR-25-383Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)NINDS · next due Jan 28, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.